Cepheid announced that it has received clearance from the FDA for Xpert BCR-ABL Ultra for monitoring disease burden in patients...
Edwards Lifesciences Corporation announced it has received CE Mark for the SAPIEN 3 Ultra system for transcatheter aortic valve replacement...
Allergan announced that the company has received approval from the FDA to market Juvederm Ultra XC (hyaluronic acid gel) for...
After issuing a recall for the Sapien 3 Ultra delivery system, from Edwards Lifesciences, in July 2019, the FDA now...
Edwards Lifesciences Corporation announced that the SAPIEN 3 Ultra system has received FDA approval for transcatheter aortic valve replacement in...
FUJIFILM VisualSonics Inc., a world leader in ultra high frequency ultrasound imaging systems and subsidiary of FUJIFILM SonoSite, Inc., announced...
Canon Medical Systems USA, Inc.'s newly FDA-cleared Aquilion Precision is the world's first Ultra-High Resolution CT system (UHR CT). The...
Readouts from two phase III clinical trials demonstrated that Eli Lilly and Company's Ultra Rapid Lispro (URLi) met the primary...
Objectives: Safe and effective contraceptive options for obese women are becoming more important due to the obesity epidemic within the...
Drug development for ultra-rare diseases is challenging because small sample sizes and heterogeneous study populations hamper the ability of randomized, placebo-controlled trials with a single primary endpoint to demonstrate valid treatment effects.